Valeria Rolih

Turin, 10126, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer.

Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer.

Journal: Cancers

Published: May 05, 2020

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.

Journal: Progress in molecular biology and translational science

Published: August 07, 2019

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.

Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporter.

Journal: Cancer immunology, immunotherapy : CII

Published: March 05, 2018

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.

Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.

Journal: Oncoimmunology

Published: February 22, 2018

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for Immunotherapy.

Journal: International journal of molecular sciences

Published: January 31, 2018

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.

A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo.

Journal: Oncoimmunology

Published: August 25, 2017

CSPG4: a prototype oncoantigen for translational immunotherapy studies.

CSPG4: a prototype oncoantigen for translational immunotherapy studies.

Journal: Journal of translational medicine

Published: February 13, 2017

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.

Protection of mice against the highly pathogenic VVIHD-J by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity.

Journal: Antiviral research

Published: July 12, 2016

Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.

Journal: Veterinary and comparative oncology

Published: February 23, 2016

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer.

Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer.

Journal: Oncoimmunology

Published: June 26, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026